Escolar Documentos
Profissional Documentos
Cultura Documentos
1. Highlights
2. 2017 performance
2 15 February 2018 Full Year 2017 Results The world leader in gases, technologies and services for Industry and Health
Highlights
Benoît Potier
Chairman & Chief Executive Officer
3 15 February 2018 Full Year 2017 Results The world leader in gases, technologies and services for Industry and Health
Highlights
4 15 February 2018 Full Year 2017 Results The world leader in gases, technologies and services for Industry and Health
Improved Performance
3% 17%
3% 16.8% Excl. energy impact
2% 2%
16.5% As published
1% 1%
16% 16.1%
0% 0%
2016 2017 Q1 17 Q2 17 Q3 17 Q4 17
5 15 February 2018 Full Year 2017 Results The world leader in gases, technologies and services for Industry and Health
Increased Dividend Proposal
€2.65
€2.2bn 2,8 20 yrs
CAGR
2,4
1,2
0,8
+19.3% +10%
0,4
0,0
1997 1999 2001 2003 2005 2007 2009 2011 2013 2015 2017
As published Excluding non-cash
non-recurring items & taxes
(1) Historical data adjusted for attribution of free shares and for a factor 0.974 reflecting the value of the rights of the capital increase completed in October 2016
(2) Subject to approval at the combined shareholders’ meeting scheduled for 16 May 2018
6 15 February 2018 Full Year 2017 Results The world leader in gases, technologies and services for Industry and Health
Improved Cash Flow and Balance Sheet
Reduced Net Debt and Gearing Continued Improvement in ROCE
Excl. 2017 positive impact on net profit of non-cash
151% one-off items
<25> 160%
10.3% >10%
140%
10%
<20> 120%
90% 80% 100% (1)
8 15 February 2018 Full Year 2017 Results The world leader in gases, technologies and services for Industry and Health
Delivering in the Short-Term…
Mega trends
Smart
Biogas Innovative
Operations Strategic
(SIO) asset
review
Voice of
Energy the
efficiency Customer
(VoC) New
organization
E-health
E-business websites
Research &
Innovation Energy Transition
Development
• Renewal of R&D • 2017 ~€290m • Hydrogen Council
centers spending in innovation
• CO2 capture
Over 3 years • ALIAD: cumulative
Cumulative €130m
~€80m investments in
investments start-ups
Digital
10 15 February 2018 Full Year 2017 Results The world leader in gases, technologies and services for Industry and Health
2017 Performance
Fabienne Lecorvaisier
Executive Vice President &
Chief Financial Officer
11 15 February 2018 Full Year 2017 Results The world leader in gases, technologies and services for Industry and Health
Sales Growth Accelerating in G&S, E&C Stabilizing
12 15 February 2018 Full Year 2017 Results The world leader in gases, technologies and services for Industry and Health
Better Economic Environment
Step-up in IP growth,
expected to stabilize in 2018 Negative FX Impact(1)
Industrial Production Year on Year in % (3-month rolling average)
-1.6%
-5.4%
FY 2017 Q4 2017
+1.5%
+0.5%
FY 2017 Q4 2017
(1) On Group sales, based on 2016 adjusted sales
13 15 February 2018 Full Year 2017 Results The world leader in gases, technologies and services for Industry and Health
Key Growth Drivers in Q4 2017
+12%
+11%
+8 %
+6 % +7 %
+5%
14 15 February 2018 Full Year 2017 Results The world leader in gases, technologies and services for Industry and Health
Base Business Contribution Firming-Up
G&S Quarterly Growth Analysis
19
START-UPS
in FY17
Strongest base
business since
Q1 2014
15 15 February 2018 Full Year 2017 Results The world leader in gases, technologies and services for Industry and Health
Q4 - Accelerating Americas, Sustained IM in Europe
+31%
FY as
published
AMERICAS EUROPE
FY 2017 FY 2017
€8,150m €6,776m
16 15 February 2018 Full Year 2017 Results The world leader in gases, technologies and services for Industry and Health
Q4 - Very Strong Asia and Middle-East
MIDDLE-EAST
AS I A - P AC I F I C & AF R I C A
FY 2017 FY 2017
€4,081m €635m
17 15 February 2018 Full Year 2017 Results The world leader in gases, technologies and services for Industry and Health
Q4 - IM Driving Growth, LI Outlook Positive
+22%
FY as published
INDUSTRIAL L AR G E
M E R C H AN T I N D U S TR I E S
FY 2017 FY 2017
€9,261m €5,336m
18 15 February 2018 Full Year 2017 Results The world leader in gases, technologies and services for Industry and Health
Q4 - Very Dynamic HC and EL
+9%
FY as published
H E AL T H C AR E E L E C TR O N I C S
FY 2017 FY 2017
€3,401m €1,644m
19 15 February 2018 Full Year 2017 Results The world leader in gases, technologies and services for Industry and Health
Low E&C, Developing GMT
Sales and Order intake(1) – in €m
500 500
E&C GMT
400 400
300 300
200 200
100 100
0 0
H1-15 H2-15 H1-16 H2-16 H1-17 H2-17 H1-15 H2-15 H1-16 H2-16 H1-17 H2-17
Sales Order intake
Sales Order intake
(1) Group and third-party order intake
20 15 February 2018 Full Year 2017 Results The world leader in gases, technologies and services for Industry and Health
Improved OIR Margin in line with NEOS
21 15 February 2018 Full Year 2017 Results The world leader in gases, technologies and services for Industry and Health
Efficiencies Above NEOS Target
FY 17 Efficiencies NEOS Cumulated Efficiencies
>€1,200m
2020
>€900m
€ 2019
323m >€600m
2018
€ 323m +€
2017 23m
22 15 February 2018 Full Year 2017 Results The world leader in gases, technologies and services for Industry and Health
2017 Airgas Cumulated Synergies Ahead of Plan
Initial(1)
Update
target
US$
>300m
215m 2019
>300m
270m
>235m
Costs ~US$190m 2018 215m
+US$
Revenue ~US$25m
2017
>175m
40m
• 2017 costs synergies US$40m above
initial target
Higher procurement synergies
Cylinder management integration 45m 45m
2016
faster than expected
(1) Defined in 2016 In US$ In US$
23 15 February 2018 Full Year 2017 Results The world leader in gases, technologies and services for Industry and Health
Positive Non-cash Exceptionals, Net Profit Recurring +10%
25 15 February 2018 Full Year 2017 Results The world leader in gases, technologies and services for Industry and Health
Significant Debt Reduction
GEARING
CASH FLOW
90%
+15% GEARING
80%
26 15 February 2018 Full Year 2017 Results The world leader in gases, technologies and services for Industry and Health
Selected Investments for the Future
€ € €
2.1bn 2.6bn 190m
800
600
400
200
€
0.8bn 0
In €m Q1-17 Q2-17 Q3-17 Q4-17
28 15 February 2018 Full Year 2017 Results The world leader in gases, technologies and services for Industry and Health
Starting-up Major LI Units in a Dynamic Environment
2018
2017
Q1 Q2 Q3 Q4
>€
2018 forecasted additional sales 370m
Increased bidding activity on new projects
29 15 February 2018 Full Year 2017 Results The world leader in gases, technologies and services for Industry and Health
2018 Outlook
31 15 February 2018 Full Year 2017 Results The world leader in gases, technologies and services for Industry and Health
Adjusted Sales Used as a Comparison Basis (1/2)
F Published growth
As of
January 1st, 2016
A B C D
32 15 February 2018 Full Year 2017 Results The world leader in gases, technologies and services for Industry and Health
Adjusted Sales Used as a Comparison Basis (2/2)
Published 2016
Published 2016 Air Liquide sales excluding Air Liquide Welding and Aqua Lung
A excluding Air Liquide
(IFRS 5, discontinued operations)
Welding and Aqua Lung
Airgas consolidated Published 2016 Airgas sales with divestments fully completed as of
B - Airgas divestments January 1st, 2016
Adjusted Air Liquide
C sales
2016 starting point: A + B
D Published 2017 Published 2017 Air Liquide sales
Growth between 2016 adjusted Air Liquide sales and published 2017 sales
E Comparable growth
D excluding change, energy and significant M&A versus C
Growth between published 2016 Air Liquide sales, excluding Air Liquide Welding
F Published growth
and Aqua Lung, and published 2017 Air Liquide sales
D versus A
2016 comparable sales growth excluding currency, energy price fluctuation and Airgas impact
33 15 February 2018 Full Year 2017 Results The world leader in gases, technologies and services for Industry and Health
FY 2017 G&S Revenue Breakdown by Region
EUROPE
€6.8bn ASIA-
AMERICAS
PACIFIC
€8.1bn €4.1bn
€19,642m
34 15 February 2018 Full Year 2017 Results The world leader in gases, technologies and services for Industry and Health
Consolidated P&L
(1) FY 2016 Basic earnings per share adjusted for the free share attribution of October 2, 2017
35 15 February 2018 Full Year 2017 Results The world leader in gases, technologies and services for Industry and Health
Operating Margin (OIR/Revenue)
FY 2017 operating margin excluding energy improved +70bps compared to adjusted FY 2016
NB: 2016 figures have been restated to account for IFRS 5, discontinued operations.
36 15 February 2018 Full Year 2017 Results The world leader in gases, technologies and services for Industry and Health
Consolidated Balance Sheet Simplified - In €m
37 15 February 2018 Full Year 2017 Results The world leader in gases, technologies and services for Industry and Health
Cash Flow Statement
38 15 February 2018 Full Year 2017 Results The world leader in gases, technologies and services for Industry and Health
Impact of Currency and Energy on G&S Revenue
(1)
(1)
(2)
(1)
(2)
● Sales backlog
– Cumulated expected sales per year generated by the current investment backlog after full ramp-up.
€1.9bn
48 15 February 2018 Full Year 2017 Results The world leader in gases, technologies and services for Industry and Health
Financing Structure
As of December 31, 2017
(1) Others: Finance leases and put options granted to minority shareholders.
49 15 February 2018 Full Year 2017 Results The world leader in gases, technologies and services for Industry and Health
Regular and Sustained Performance
21 000
Revenue (in €m) +6.0% EPS(1) (in €) +7.5%
18 000 C AG R C AG R
5,0
15 000 over 30 years
(2) (2)
over 30 years
4,0
12 000
3,0
9 000
2,0
6 000
1,0
3 000
0 0,0
1987 1989 1991 1993 1995 1997 1999 2001 2003 2005 2007 2009 2011 2013 2015 2017 1987 1989 1991 1993 1995 1997 1999 2001 2003 2005 2007 2009 2011 2013 2015 2017
4 500
Cashflow (in €m) +6.9% 3,0 Dividend(1) (in € per share) +8.6%
4 000 C AG R 2,5 C AG R
3 500
over 30 years
(2) (2)
over 30 years
3 000 2,0
2 500
1,5
2 000
1 500 1,0
1 000
0,5
500
0 0,0
1987 1989 1991 1993 1995 1997 1999 2001 2003 2005 2007 2009 2011 2013 2015 2017 1987 1989 1991 1993 1995 1997 1999 2001 2003 2005 2007 2009 2011 2013 2015 2017
(1) Adjusted for the 2-for-1 share split in 2007, for attributions of free shares and for a factor of 0.974 reflecting the value of the rights of the capital increase
completed in October 2016. (2) Calculated according to prevailing accounting rules over 30 years.
50 15 February 2018 Full Year 2017 Results The world leader in gases, technologies and services for Industry and Health
For further information, please contact:
Corporate Headquarters:
75, Quai d’Orsay
L’Air Liquide S.A. 75321 Paris Cedex 07
Corporation for the study and application of processes developed by Georges Claude Tel : +33 (0)1 40 62 55 55
with registered capital of 2,356,439,277.50 euros RCS Paris 552 096 281
51 15 February 2018 Full Year 2017 Results The world leader in gases, technologies and services for Industry and Health